Full-Time

Director – Program Management

Commercial

Posted on 8/6/2024

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$190k - $225kAnnually

Senior, Expert

Pasadena, CA, USA

Requires in-office presence 5 days a week.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Bachelor’s degree in Biology, Chemistry, Business, or related area
  • 10+ years in the life-sciences, pharmaceutical industry
  • At least 5+ years equivalent multi-/ cross-functional program leadership experience
  • Previous work and leadership experience in program management of globally approved medicines
  • Demonstrated program management experience with Phase 3, Phase 4, and commercial-stage assets
  • Broad operational experience with an understanding of drug development, launch and commercialization process
  • Advanced Project Management skills
  • Ability to work collaboratively in a matrixed, team-based environment, with strong organizational and time management capabilities
  • Advanced knowledge of regulatory and business requirements
  • Understands basic financial aspects, including knowledge of resource planning (headcount and budget) and management
  • Expert planning and tracking skills, able to see big picture, well-organized, focused on results, capable of managing multiple projects, excellent time management with respect to priorities and self-management
  • Strong interpersonal and communication skills for bridging between scientific and business participants, for negotiating timelines and for effective collaboration.
  • You may be required to travel for up to 10% of your time
Responsibilities
  • Drives the process for the elaboration, maintenance and execution of the integrated product launch and commercialization strategy for one or more late stage and commercial pharmaceutical products.
  • Works closely with commercial, finance, business, clinical, regulatory, medical affairs, CMC and other functions to assure commercial success.
  • Drive decision-making and issues resolution through governance
  • Responsible for development of the operational plan including realistic timelines, budget and resources planning, risk assessment and contingency planning.
  • Ensures cross-functional alignment and organizational support for the execution of the operational plan by facilitating internal and external stakeholder meetings.
  • Responsible for monitoring and tracking the project against approved timelines and milestones and ensures adherence to agreed-upon team objectives and deliverables.
  • Manages prioritization of program team activities to enhance program value.
  • Responsible for comprehensiveness and quality of program information in the internal systems, databases, and communication to Senior Management.
  • Expected to identify bottlenecks, surface issues, and proactively drive for their resolution.
  • Accountable for accurate forecasting, tracking and adherence to program budget (headcount and external costs) by liaising with team members. Challenges assumptions, timelines and expenses on program level.
  • Manages project variance and root cause analysis, develops risk mitigation / issue management plans with the objective to meet the financial targets.
  • Ensures effective, proactive and open communications, horizontally and vertically, in order to achieve transparency and clarity of program goals, progress and issues.
  • Responsible for high performing and healthy program team
  • Identifies and resolves conflicts at functional team level
  • Create healthy work team environment
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing the genes responsible for them. The company uses RNA interference (RNAi), a natural process that reduces the expression of specific genes, to achieve effective gene silencing. This method allows for significant reduction in the activity of harmful genes, which can help stop or even reverse the progression of diseases like cystic fibrosis and hepatitis B. Arrowhead stands out from its competitors by focusing specifically on RNAi-based therapies and leveraging a wide range of RNA chemistries and delivery methods. The company aims to meet unmet medical needs by providing new treatment options for genetic disorders, and it generates revenue through partnerships, licensing agreements, and potential sales of its therapies after regulatory approval.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead secured a $500 million facility with Sixth Street for pipeline advancement.
  • Positive Phase 2 data for plozasiran shows promise in treating severe hypertriglyceridemia.
  • Collaboration with Sarepta Therapeutics brings significant financial and research benefits.

What critics are saying

  • Increased competition from companies like Alnylam Pharmaceuticals in the RNAi space.
  • Potential regulatory scrutiny could delay clinical trials for RNAi therapies.
  • Financial instability risk due to reliance on strategic financing agreements.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi to target and silence disease-causing genes effectively.
  • The company has a broad portfolio of RNA chemistries for diverse therapeutic applications.
  • Arrowhead's strategic partnerships enhance its research and development capabilities.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE